PRW Insider Trading Activity and SEC Form 4 Filings
PRW insider trading summary
No open-market insider purchases or sales of Pro Pharmaceuticals Inc (PRW) have been reported on SEC Form 4 in the past 12 months.
Latest PRW insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 19, 2008 | Theodore Daniel Zucconi | President | Buy | $60 (300 @ $0.20) |
| Sep 19, 2008 | Theodore Daniel Zucconi | President | Buy | $391 (1,700 @ $0.23) |
| Sep 19, 2008 | James Theophile Gourzis | Director | Buy | $440 (2,000 @ $0.22) |
| Sep 18, 2008 | Theodore Daniel Zucconi | President | Buy | $600 (3,000 @ $0.20) |
| Sep 18, 2008 | Theodore Daniel Zucconi | President | Buy | $999 (4,000 @ $0.25) |
| Sep 18, 2008 | Theodore Daniel Zucconi | President | Buy | $400 (2,000 @ $0.20) |
| Sep 18, 2008 | David Platt | Chairman & CEO | Buy | $230 (1,000 @ $0.23) |
| Mar 29, 2007 | Dale H Conaway | Director | Buy | $300 (400 @ $0.75) |
| Mar 5, 2007 | Dale H Conaway | Director | Buy | $2K (2,000 @ $1.08) |
| Feb 15, 2007 | Dale H Conaway | Director | Buy | $72 (60 @ $1.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.